SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism. Habas E, Rayani A, Habas A, Alarbi K, et al. Ren Fail 2026;48:2688578.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Habas E, Rayani A, Habas A, Alarbi K, et al. SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism. Ren Fail 2026;48:2688578.
PMID: 42392584